Welcome to our dedicated page for Allstate SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allstate Corporation filings document the insurer's operating results, Regulation FD updates, governance matters and registered capital structure. Recent Form 8-K reports include quarterly and annual financial results, investor supplements, estimated catastrophe losses and policies in force for Allstate Protection.
Allstate's proxy materials describe board matters, executive compensation and shareholder voting items. Its filing cover pages identify common stock, fixed-to-floating subordinated debentures due 2053, and depositary shares representing Series H, Series I and Series J noncumulative preferred stock registered on public exchanges.
The Allstate Corporation reported a planned change in its board leadership. Long-time director Gregg M. Sherrill, who has served on the board since 2017 and as Lead Director since 2021, will retire from the board effective November 21, 2025. The company states that his retirement does not involve any disagreement with Allstate.
Upon Mr. Sherrill’s retirement, director Richard T. Hume, a board member since 2020, will become the new Lead Director effective the same date. This filing focuses solely on these governance changes and does not report any financial results or major transactions.
The Allstate Corporation reported a planned change in its board leadership. Long-time director Gregg M. Sherrill, who has served on the board since 2017 and as Lead Director since 2021, will retire from the board effective November 21, 2025. The company states that his retirement does not involve any disagreement with Allstate.
Upon Mr. Sherrill’s retirement, director Richard T. Hume, a board member since 2020, will become the new Lead Director effective the same date. This filing focuses solely on these governance changes and does not report any financial results or major transactions.
The Allstate Corporation reported a planned change in its board leadership. Long-time director Gregg M. Sherrill, who has served on the board since 2017 and as Lead Director since 2021, will retire from the board effective November 21, 2025. The company states that his retirement does not involve any disagreement with Allstate.
Upon Mr. Sherrill’s retirement, director Richard T. Hume, a board member since 2020, will become the new Lead Director effective the same date. This filing focuses solely on these governance changes and does not report any financial results or major transactions.
The Allstate Corporation filed a Form 8-K to provide a Regulation FD disclosure about its October 2025 monthly release. The company states that a press release announcing estimated catastrophe losses and policies in force for October 2025 has been posted on allstateinvestors.com and is attached as Exhibit 99.
The press release is dated November 20, 2025 and is being furnished, not filed, under Item 7.01, which affects how it is treated for certain securities law purposes. The filing also lists Allstate’s common stock and various preferred and subordinated securities traded on the New York Stock Exchange.
The Allstate Corporation filed a Form 8-K to provide a Regulation FD disclosure about its October 2025 monthly release. The company states that a press release announcing estimated catastrophe losses and policies in force for October 2025 has been posted on allstateinvestors.com and is attached as Exhibit 99.
The press release is dated November 20, 2025 and is being furnished, not filed, under Item 7.01, which affects how it is treated for certain securities law purposes. The filing also lists Allstate’s common stock and various preferred and subordinated securities traded on the New York Stock Exchange.
The Allstate Corporation filed a Form 8-K to provide a Regulation FD disclosure about its October 2025 monthly release. The company states that a press release announcing estimated catastrophe losses and policies in force for October 2025 has been posted on allstateinvestors.com and is attached as Exhibit 99.
The press release is dated November 20, 2025 and is being furnished, not filed, under Item 7.01, which affects how it is treated for certain securities law purposes. The filing also lists Allstate’s common stock and various preferred and subordinated securities traded on the New York Stock Exchange.
The Allstate Corporation (ALL) reported that its Chairman, President & CEO, Thomas J. Wilson, sold Allstate common stock in open-market transactions on 11/17/2025. He sold 15,370 shares at a weighted average price of $213.1159, 1,137 shares at $213.9619, and 300 shares at $214.7028, with actual prices in disclosed ranges for each trade. These sales were made under a Rule 10b5-1 trading plan adopted on June 27, 2025, which is a pre-arranged plan for systematic stock sales. Following the reported transactions, Wilson beneficially owned 161,619.491 Allstate shares directly, in addition to multiple indirect holdings through various GRATs, a 401(k) plan, and a remainder trust.
The Allstate Corporation (ALL) reported an insider equity transaction by President, Enterprise Solutions, Suren Gupta. On 11/17/2025, Gupta exercised 400 employee stock options at an exercise price of $62.32 per share and then sold 400 shares of common stock in an open-market transaction at a weighted average price of $215.215 per share. These trades were made under a Rule 10b5-1(c) trading plan adopted on June 9, 2025. Following the transactions, Gupta beneficially owns 100,646 common shares directly, plus 1,329 shares through a 401(k) plan and 7 shares via VVG Holdings LLC, and holds 46,600 stock options for Allstate common stock.
Allstate Corporation (ALL) reported insider activity by President, Enterprise Solutions, Suren Gupta. On 11/14/2025 he exercised 1,400 stock options at $62.32 per share and sold 1,400 common shares at a weighted average price of $215.0221 per share under a pre-arranged Rule 10b5-1 trading plan adopted on June 9, 2025. On 11/17/2025, 385 shares were transferred as a gift at a price of $0. Following these transactions, he directly owns 100,646 Allstate shares, plus 1,329 shares through a 401(k) plan and 7 shares through VVG Holdings LLC.
Allstate Corporation insider plans a small stock sale under Rule 144. The notice covers the proposed sale of 400 shares of common stock of Allstate on the NYSE through Fidelity Brokerage Services LLC. These 400 shares were acquired on 11/17/2025 via an option granted on 02/11/2016, with payment made in cash on the same date. The filing also reports that the same seller, Suren K. Gupta, sold 1,400 shares of common stock on 11/14/2025 for gross proceeds of 301,030.94. Allstate had 261,681,708 shares of common stock outstanding, providing context for the relatively small size of these transactions.
Allstate (ALL): Form 144 notice of proposed sale
A security holder filed to sell 1,400 shares of Allstate common stock under Rule 144. The filing lists an aggregate market value of $301,031.00 and an approximate sale date of 11/14/2025. The planned broker is Fidelity Brokerage Services LLC, and the shares are to be sold on the NYSE.
The filing notes the shares were acquired via options granted on 02/11/2016, with payment on 11/14/2025 in cash. Shares outstanding were 261,681,708, providing baseline context separate from the proposed sale amount.
Allstate Corp: T. Rowe Price Associates, Inc. filed Amendment No. 1 to Schedule 13G reporting beneficial ownership of 12,972,686 Allstate common shares, equal to 4.9% of the class as of 09/30/2025.
The filer reports sole voting power over 12,431,384 shares and sole dispositive power over 12,965,140 shares, with no shared voting or dispositive power. The filing is made in the capacity of an investment adviser under Rule 13d‑1(b), and certifies the securities were acquired and are held in the ordinary course, not to change or influence control. Item 5 indicates ownership of 5 percent or less of the class.
Allstate (ALL) reported stronger quarterly results. For Q3 2025, total revenue was $17.3 billion, up from $16.6 billion a year ago. Net income rose to $3.7 billion from $1.2 billion, and diluted EPS increased to $13.95 from $4.33.
Results benefited from a $720 million gain on disposition of operations, higher net investment income ($949 million vs. $783 million), and lower property and casualty claims and claims expense ($8.7 billion vs. $10.4 billion). Accident and health premiums were lower ($110 million vs. $487 million) as that business continued to shrink.
The balance sheet strengthened, with total assets of $120.4 billion and Allstate shareholders’ equity of $27.5 billion as of September 30, 2025. Accumulated other comprehensive income improved to a $298 million gain. Year-to-date operating cash flow was $7.1 billion, while the company repurchased treasury stock and paid common and preferred dividends. As of October 20, 2025, common shares outstanding were 261,681,708.
The Allstate Corporation (ALL) reported insider activity: Chairman, President & CEO Thomas J. Wilson sold a total of 16,807 shares of common stock on 11/03/2025 through multiple open‑market transactions executed under a Rule 10b5‑1 trading plan adopted on June 27, 2025.
The weighted average sale prices were $188.7305 (5,930 shares), $189.3931 (7,791 shares), $190.4249 (2,101 shares), and $191.3729 (985 shares), with disclosed price ranges for each tranche. Following these sales, Wilson directly beneficially owns 178,426.491 shares.